Literature DB >> 7287187

Respiratory infectivity of a recently isolated Egyptian strain of Rift Valley fever virus.

J L Brown, J W Dominik, R L Morrissey.   

Abstract

The respiratory infectivity of a strain of Rift Valley fever virus isolated in Egypt (strain ZH-501) was compared with that of one isolate from Uganda (Entebbe strain) and two isolates from South Africa (strains SA-51 and SA-75). Studies were performed with ICR mice which were infected by exposure to infectious aerosols composed of particles with a mass median diameter of 0.96 micrometer. The respiratory median lethal doses for ZH-501, Entebbe, SA-51, and SA-75 were 2.2, 1.9, 2.6, and 1.9 log10 plaque-forming units, respectively. Although these values are statistically different, the biological implications of such differences seem unimportant. In an additional study of pathogenesis, a single group of mice was infected with 3.1 log10 plaque-forming units of ZH-501, and tissues were assayed sequentially through 96 h postinfection. Between 6 and 30 h, demonstration of an increasing virus concentration only in the lungs indicated that initial replication occurred there; however, determination of histopathological changes did not reveal evidence of pneumonia. Virus was isolated from the liver by 48 h, and the ultimate outcome of infection was a fulminating and fatal hepatic necrosis.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7287187      PMCID: PMC350789          DOI: 10.1128/iai.33.3.848-853.1981

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  11 in total

1.  STUDIES ON RIFT VALLEY FEVER IN LABORATORY ANIMALS.

Authors:  B C EASTERDAY; L C MURPHY
Journal:  Cornell Vet       Date:  1963-07

2.  SINGLE-STAGE IMPACTION DEVICE FOR PARTICLE SIZING BIOLOGICAL AEROSOLS.

Authors:  J E MALLIGO; L S IDOINE
Journal:  Appl Microbiol       Date:  1964-01

3.  An apparatus for the study of airborne infection.

Authors:  D W HENDERSON
Journal:  J Hyg (Lond)       Date:  1952-03

4.  Susceptibility of dogs and cats to Rift Valley fever by inhalation or ingestion of virus.

Authors:  G V Keefer; G L Zebarth; W P Allen
Journal:  J Infect Dis       Date:  1972-03       Impact factor: 5.226

Review 5.  Rift valley fever.

Authors:  B C Easterday
Journal:  Adv Vet Sci       Date:  1965

6.  Epidemic Rift Valley fever in Egypt: observations of the spectrum of human illness.

Authors:  L W Laughlin; J M Meegan; L J Strausbaugh; D M Morens; R H Watten
Journal:  Trans R Soc Trop Med Hyg       Date:  1979       Impact factor: 2.184

7.  The Rift Valley fever epizootic in Egypt 1977-78. 1. Description of the epizzotic and virological studies.

Authors:  J M Meegan
Journal:  Trans R Soc Trop Med Hyg       Date:  1979       Impact factor: 2.184

8.  Dose-response of guinea pigs experimentally infected with aerosols of Legionella pneumophila.

Authors:  R F Berendt; H W Young; R G Allen; G L Knutsen
Journal:  J Infect Dis       Date:  1980-02       Impact factor: 5.226

9.  Rift Valley Fever virus infections in Egypt: Pathological and virological findings in man.

Authors:  K S Abdel-Wahab; L M El Baz; E M El-Tayeb; H Omar; M A Ossman; W Yasin
Journal:  Trans R Soc Trop Med Hyg       Date:  1978       Impact factor: 2.184

10.  An epizootic of Rift Valley fever in Egypt in 1977.

Authors:  J M Meegan; H Hoogstraal; M I Moussa
Journal:  Vet Rec       Date:  1979-08-11       Impact factor: 2.695

View more
  23 in total

Review 1.  Emerging Infections of CNS: Avian Influenza A Virus, Rift Valley Fever Virus and Human Parechovirus.

Authors:  Clayton A Wiley; Nitin Bhardwaj; Ted M Ross; Stephanie J Bissel
Journal:  Brain Pathol       Date:  2015-09       Impact factor: 6.508

2.  The genetic basis for susceptibility to Rift Valley fever disease in MBT/Pas mice.

Authors:  S Tokuda; T Z Do Valle; L Batista; D Simon-Chazottes; L Guillemot; M Bouloy; M Flamand; X Montagutelli; J-J Panthier
Journal:  Genes Immun       Date:  2015-01-08       Impact factor: 2.676

3.  Aerosolized rift valley fever virus causes fatal encephalitis in african green monkeys and common marmosets.

Authors:  Amy L Hartman; Diana S Powell; Laura M Bethel; Amy L Caroline; Richard J Schmid; Tim Oury; Douglas S Reed
Journal:  J Virol       Date:  2013-12-11       Impact factor: 5.103

4.  An investigation of a major outbreak of Rift Valley fever in Kenya: 2006-2007.

Authors:  Patrick M Nguku; S K Sharif; David Mutonga; Samuel Amwayi; Jared Omolo; Omar Mohammed; Eileen C Farnon; L Hannah Gould; Edith Lederman; Carol Rao; Rosemary Sang; David Schnabel; Daniel R Feikin; Allen Hightower; M Kariuki Njenga; Robert F Breiman
Journal:  Am J Trop Med Hyg       Date:  2010-08       Impact factor: 2.345

5.  Risk factors for severe Rift Valley fever infection in Kenya, 2007.

Authors:  Amwayi S Anyangu; L Hannah Gould; Shahnaaz K Sharif; Patrick M Nguku; Jared O Omolo; David Mutonga; Carol Y Rao; Edith R Lederman; David Schnabel; Janusz T Paweska; Mark Katz; Allen Hightower; M Kariuki Njenga; Daniel R Feikin; Robert F Breiman
Journal:  Am J Trop Med Hyg       Date:  2010-08       Impact factor: 2.345

6.  A complex adenovirus-vectored vaccine against Rift Valley fever virus protects mice against lethal infection in the presence of preexisting vector immunity.

Authors:  David H Holman; Adam Penn-Nicholson; Danher Wang; Jan Woraratanadharm; Mary-Katherine Harr; Min Luo; Ellen M Maher; Michael R Holbrook; John Y Dong
Journal:  Clin Vaccine Immunol       Date:  2009-09-23

7.  Rift Valley fever virus(Bunyaviridae: Phlebovirus): an update on pathogenesis, molecular epidemiology, vectors, diagnostics and prevention.

Authors:  Michel Pepin; Michele Bouloy; Brian H Bird; Alan Kemp; Janusz Paweska
Journal:  Vet Res       Date:  2010 Nov-Dec       Impact factor: 3.683

8.  Rift Valley fever virus NSs protein promotes post-transcriptional downregulation of protein kinase PKR and inhibits eIF2alpha phosphorylation.

Authors:  Tetsuro Ikegami; Krishna Narayanan; Sungyong Won; Wataru Kamitani; C J Peters; Shinji Makino
Journal:  PLoS Pathog       Date:  2009-02-06       Impact factor: 6.823

9.  Aedes mosquito saliva modulates Rift Valley fever virus pathogenicity.

Authors:  Alain Le Coupanec; Divya Babin; Laurence Fiette; Grégory Jouvion; Patrick Ave; Dorothee Misse; Michèle Bouloy; Valerie Choumet
Journal:  PLoS Negl Trop Dis       Date:  2013-06-13

10.  Aerosol exposure to Rift Valley fever virus causes earlier and more severe neuropathology in the murine model, which has important implications for therapeutic development.

Authors:  Christopher Reed; Kenny Lin; Catherine Wilhelmsen; Brian Friedrich; Aysegul Nalca; Ashley Keeney; Ginger Donnelly; Joshua Shamblin; Lisa E Hensley; Gene Olinger; Darci R Smith
Journal:  PLoS Negl Trop Dis       Date:  2013-04-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.